India - Considerations to Improve Patient Outcomes in Early Drug Development - Seguridad Mania.com - España y América Latina

Every drug development program must begin with an understanding of how the relevant key stakeholders factor into the development process. It’s not just a matter of courtesy; a comprehensive examination of the roles played by all participants has the potential to produce faster and more concrete results, leading to improved patient outcomes. Watch this webinar to learn about these and other vital product development considerations, such as: - Developing a framework for handling multiple endpoints for the drug’s go-to-market label - Determining the potential of adaptive design for optimizing the trial and evaluating the applicability of various adaptive design approaches - Key interactions and questions to ask when seeking regulatory input of pivotal study designs Presenters: Abie Ekangaki, Ph.D., Vice President, Statistical Consulting, Premier Research Rupa Doshi, Ph.D., Vice President, Oncology Strategy, Premier Research Naomi Kautz, Vice President, Regulatory Affairs, Premier Consulting Please note: If Premier Research does not attend to your questions during the webinar, Premier Research may follow up after the presentation directly with a response.